These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8026542)

  • 21. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of neurotensin receptors in intestinal smooth muscle using a nonpeptide antagonist.
    Unno T; Komori S; Ohashi H
    Eur J Pharmacol; 1999 Mar; 369(1):73-80. PubMed ID: 10204684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
    Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
    Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
    Pinnock RD; Woodruff GN
    Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of peristalsis by neurotensin in isolated guinea-pig intestinal segments.
    Ohashi H; Tanaka K; Kiuchi N; Unno T; Komori S
    Eur J Pharmacol; 1996 Apr; 301(1-3):129-36. PubMed ID: 8773456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain.
    Chrétien L; Guillemette G; Regoli D
    Eur J Pharmacol; 1994 Apr; 256(1):73-8. PubMed ID: 7517891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.
    Nicot A; Bérod A; Gully D; Rowe W; Quirion R; de Kloet ER; Rostène W
    Neuroendocrinology; 1994 Jun; 59(6):572-8. PubMed ID: 8084381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological heterogeneity of neurotensin receptors: an in vitro study.
    Nguyen-Le XK; Neugebauer W; Gobeil F; Pheng LH; Nsa Allogho S; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):547-51. PubMed ID: 9276126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
    Chen L; Yung KK; Yung WH
    Neuroscience; 2004; 125(4):853-9. PubMed ID: 15120846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum.
    Steinberg R; Rodier D; Mons G; Gully D; Le Fur G; Soubrié P
    Neuropeptides; 1995 Jul; 29(1):27-31. PubMed ID: 7566510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in [
    Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
    Schaeffer P; Laplace MC; Bernat A; Prabonnaud V; Gully D; Lespy L; Herbert JM
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):545-50. PubMed ID: 9554803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoradiographic and electrophysiological evidence for the existence of neurotensin receptors on cultured astrocytes.
    Hösli E; Stauffer S; Hösli L
    Neuroscience; 1995 Jun; 66(3):627-33. PubMed ID: 7644026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
    Miller LA; Cochrane DE; Feldberg RS; Carraway RE
    Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.
    Croci T; Aureggi G; Guagnini F; Manara L; Gully D; Fur GL; Maffrand JP; Mukenge S; Ferla G; Ferrara P; Chalon P; Vita N
    Br J Pharmacol; 1999 Aug; 127(8):1922-8. PubMed ID: 10482925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotensin decreases high affinity [3H]-ouabain binding to cerebral cortex membranes.
    Rosin C; Ordieres MG; Arnaiz GR
    Regul Pept; 2011 Dec; 172(1-3):35-40. PubMed ID: 21896291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
    Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
    Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.